Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03636880 · ClinicalTrials.gov registry record · NA

Heart Failure Insomnia Treatment Study

A NA study, sponsored by Ohio State University.

Completed
Registry status
NA
Development phase
76
Enrollment target

NCT03636880 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 76 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03636880, a NA study, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
NA
Development phase
76 participants
Enrollment target

Study Summary

The purpose of this study is to compare a short, behavioral treatment for insomnia with sleep monitoring to determine whether these approaches are effective in reducing insomnia and improving sleep quality among patients with heart failure (HF). This study will also examine the relationship between insomnia and cognitive functioning in HF and the effects of the behavioral treatment on cognitive functioning, self-care, distress, HF symptoms, and functional status. Participants will be randomly assigned to four-sessions of a behavioral treatment (Brief Behavioral Treatment for Insomnia; BBTI) or sleep monitoring.

Interventions

  • BEHAVIORAL Brief treatment for Insomnia
  • BEHAVIORAL Sleep Monitoring

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2017-02-24
Est. Completion 2023-08-29
Phase NA

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT03636880

The ClinicalTrials.gov registry entry for NCT03636880 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Brief treatment for Insomnia is the first listed.

NCT03636880 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03636880 about?

NCT03636880 is a clinical study titled "Heart Failure Insomnia Treatment Study". The purpose of this study is to compare a short, behavioral treatment for insomnia with sleep monitoring to determine whether these approaches are effective in reducing insomnia and improving sleep quality among patients with heart failure (HF). This study will also examine the relationship between ...

What is the current status of trial NCT03636880?

This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2017-02-24. Estimated completion is 2023-08-29.

What interventions are being tested in trial NCT03636880?

The interventions under investigation include: Brief treatment for Insomnia (BEHAVIORAL), Sleep Monitoring (BEHAVIORAL).

Who is sponsoring clinical trial NCT03636880?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.